Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

12.53
-0.8300-6.21%
Post-market: 12.530.00000.00%16:33 EDT
Volume:800.18K
Turnover:10.32M
Market Cap:1.67B
PE:-6.87
High:13.44
Open:13.36
Low:12.50
Close:13.36
Loading ...

Centessa Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Raphael Deferiere

Reuters
·
Yesterday

Centessa Pharmaceuticals Appoints Raphael Deferiere as Chief Accounting Officer

Reuters
·
29 May

Needham Initiates Centessa Pharmaceuticals ADR at Buy With $35 Price Target

MT Newswires Live
·
28 May

Centessa initiated with a Buy at Needham

TIPRANKS
·
28 May

Centessa Pharmaceuticals Initiated at Buy by Needham

Dow Jones
·
28 May

Centessa Pharmaceuticals (CNTA) Receives a Buy from Piper Sandler

TIPRANKS
·
20 May

Director Arjun Goyal Reports Acquisition of Common Shares in Centessa Pharmaceuticals plc

Reuters
·
20 May

Centessa Pharmaceuticals to Participate in Jefferies 2025 Global Healthcare Conference

Reuters
·
19 May

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
19 May

Centessa Pharmaceuticals Posts Revenue, Q1 Net Loss Narrows

MT Newswires Live
·
14 May

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M

MT Newswires Live
·
14 May

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
14 May

Centessa Pharmaceuticals Q1 EPS $(0.20) Beats $(0.37) Estimate, Sales $15.00M

Benzinga
·
14 May

Centessa Pharmaceuticals Reports Q1 2025 Results: Net Loss Narrows to $26.1M, R&D Expenses Increase by 47%

Reuters
·
14 May

Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Dow Jones
·
14 May

Centessa Pharmaceuticals Initiated at Buy by Chardan Capital

Dow Jones
·
08 May

Chardan Initiates Centessa Pharmaceuticals at Buy With $30 Price Target

MT Newswires Live
·
08 May

Iqbal J. Hussain, General Counsel, Reports Disposal of Common Shares in Centessa Pharmaceuticals plc

Reuters
·
03 May

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target

MT Newswires Live
·
31 Mar

Centessa Pharmaceuticals Initiated at Overweight by Piper Sandler

Dow Jones
·
31 Mar